aspirin has been researched along with rabeprazole in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 17 (73.91) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jansen, JB; Laheij, RJ; Van Rossum, LG; Verheugt, FW | 1 |
| Kotaira, J | 1 |
| Desipio, J; Fisher, RS; Irani, S; Kim-Jaffe, J; Krevsky, B; Maqbool, S | 1 |
| Furuta, T; Hishida, A; Ikuma, M; Kodaira, C; Nishino, M; Shirai, N; Sugimoto, M; Sugimura, H; Tanaka, T; Yamade, M | 1 |
| Furuta, T; Hishida, A; Ikuma, M; Kodaira, C; Nishino, M; Sugimoto, M; Sugimura, H; Tanaka, T; Yamade, M | 1 |
| Nathisuwan, S; Panomvana, D; Sansanayudh, N; Siriswangvat, S | 1 |
| Chubachi, H; Ikee, R; Miyasaka, Y; Saito, S; Yasu, T | 1 |
| Chen, LC; Hou, MC; Huang, KW; Lee, FY; Lee, SD; Leu, HB; Li, CP; Lin, HC; Lu, CL; Luo, JC | 1 |
| Furuta, T; Ikuma, M; Kodaira, C; Nishino, M; Sugimoto, M; Uotani, T; Yamade, M | 1 |
| Horiuchi, H; Ikeda, T; Imai, M; Jinnai, T; Kato, Y; Kimura, T; Makiyama, T; Shirakawa, R; Tada, T; Tazaki, J; Yamane, K | 1 |
| Azuma, T; Fujisawa, T; Fujita, T; Hayakumo, T; Inokuchi, H; Kawai, T; Kutsumi, H; Kuwayama, H; Matsubara, Y; Miyaji, H; Murakami, M; Sanuki, T; Terao, S; Yamazaki, Y; Yoshida, S | 1 |
| Furuta, T; Kodaira, C; Miyajima, H; Nishino, M; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Tanaka, T; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M | 1 |
| Arakawa, T; Fujimoto, K; Fujishiro, M; Higuchi, K; Iwakiri, R; Kato, M; Kinoshita, Y; Nakagawa, H; Ogawa, H; Okada, Y; Sanomura, M; Sugisaki, N; Takeuchi, T; Watanabe, T; Yamauchi, M | 1 |
| Fujimoto, K; Iwakiri, R | 1 |
| Howden, CW | 1 |
| Cheng, K; Guo, WY; Liu, LP; Si, R; Wang, Y; Yuan, M | 1 |
| Abe, T; Arakawa, T; Chan, FK; Chan, H; Cheong, PK; Ching, JY; Fujimoto, K; Handa, O; Higuchi, K; Kinoshita, Y; Kyaw, M; Lam, K; Lee, V; Lo, A; Lui, R; Mishiro, T; Naito, Y; Nebiki, H; Ng, SC; Sakata, Y; Takeuchi, T; Tang, RS; Tanigawa, T; Tse, YK; Watanabe, T; Wu, JC | 1 |
| Goh, KL; Zou, D | 1 |
| Ikeuchi, S; Kato, M; Kinoshita, Y; Sugizaki, K | 1 |
2 review(s) available for aspirin and rabeprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
East Asian perspective on the interaction between proton pump inhibitors and clopidogrel.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anticoagulants; Asia, Eastern; Asian People; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Dexlansoprazole; Drug Interactions; Drug Therapy, Combination; Gastroesophageal Reflux; Gastrointestinal Hemorrhage; Humans; Isoenzymes; Pantoprazole; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Ticlopidine | 2017 |
13 trial(s) available for aspirin and rabeprazole
| Article | Year |
|---|---|
Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Double-Blind Method; Female; Gastroesophageal Reflux; Gastrointestinal Diseases; Heartburn; Humans; Male; Middle Aged; Nausea; Omeprazole; Pain; Proton Pump Inhibitors; Rabeprazole | 2003 |
[Prospective comparative study on protective effect of the proton pump inhibitor and the prostaglandin analog on H. pylori-negative gastric mucosa of healthy subjects against low-dose aspirin].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Enzyme Inhibitors; Female; Gastric Mucosa; Gastroscopy; Humans; Male; Misoprostol; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer | 2004 |
Rapid protection of the gastroduodenal mucosa against aspirin-induced damage by rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Female; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Male; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Time Factors | 2008 |
Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Aspirin; Biopsy; Cytochrome P-450 CYP2C19; Female; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastroscopy; Genotype; Humans; Hydrogen-Ion Concentration; Male; Phenotype; Proton Pump Inhibitors; Rabeprazole; Severity of Illness Index; Stomach Ulcer; Young Adult | 2010 |
Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Aspirin; Cross-Over Studies; Cytochrome P-450 CYP2C19; DNA; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Esophageal pH Monitoring; Esophagitis, Peptic; Esophagoscopy; Female; Gastric Mucosa; Gastroesophageal Reflux; Genotype; Heartburn; Humans; Japan; Male; Mutation; Platelet Aggregation Inhibitors; Rabeprazole; Young Adult | 2010 |
Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Diphosphate; Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabeprazole; Ticlopidine; Treatment Outcome | 2010 |
Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Rabeprazole; Regression Analysis; Ticlopidine; Treatment Outcome | 2011 |
Impact of acid inhibition on esophageal mucosal injury induced by low-dose aspirin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aspirin; Cross-Over Studies; Esophagus; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Gastroscopy; Humans; Lansoprazole; Male; Mucous Membrane; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome; Young Adult | 2012 |
Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Esophagitis; Female; Gefarnate; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Prospective Studies; Rabeprazole; Secondary Prevention | 2012 |
Ability of rabeprazole to prevent gastric mucosal damage from clopidogrel and low doses of aspirin depends on CYP2C19 genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Aspirin; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Genotype; Humans; Male; Peptic Ulcer; Rabeprazole; Severity of Illness Index; Ticlopidine; Treatment Outcome; Young Adult | 2012 |
Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin.
Topics: Aged; Anti-Ulcer Agents; Aspirin; Double-Blind Method; Duodenal Ulcer; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Rabeprazole; Recurrence; Secondary Prevention; Stomach Ulcer | 2014 |
Esomeprazole and rabeprazole did not reduce antiplatelet effects of aspirin/clopidogrel dual therapy in patients undergoing percutaneous coronary intervention: a prospective, randomized, case-control study.
Topics: Aged; Aspirin; Case-Control Studies; Cell Adhesion Molecules; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Microfilament Proteins; Middle Aged; Percutaneous Coronary Intervention; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Ticlopidine | 2016 |
Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Topics: Aged; Aged, 80 and over; Aspirin; Double-Blind Method; Famotidine; Female; Hemoglobins; Histamine H2 Antagonists; Humans; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Rabeprazole; Recurrence; Risk Factors; Secondary Prevention | 2017 |
8 other study(ies) available for aspirin and rabeprazole
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Efficacy and safety of concomitant use of rabeprazole during dual-antiplatelet therapy with clopidogrel and aspirin after drug-eluting stent implantation: a retrospective cohort study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Cohort Studies; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Interactions; Drug-Eluting Stents; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Ticlopidine; Treatment Outcome | 2010 |
Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Asian People; Aspirin; Case-Control Studies; Clopidogrel; Coronary Artery Disease; Cross-Over Studies; Drug Therapy, Combination; Enzyme Inhibitors; Female; Histamine H2 Antagonists; Humans; Male; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Ticlopidine | 2012 |
PPI vs. teprenone in preventing recurrence of ulcers during low-dose aspirin - authors' reply.
Topics: Anti-Ulcer Agents; Aspirin; Duodenal Ulcer; Female; Fibrinolytic Agents; Humans; Male; Rabeprazole; Stomach Ulcer | 2014 |
PPI vs. teprenone in preventing recurrence of ulcers during low-dose aspirin.
Topics: Anti-Ulcer Agents; Aspirin; Duodenal Ulcer; Female; Fibrinolytic Agents; Humans; Male; Rabeprazole; Stomach Ulcer | 2014 |
Rabeprazole Coadministration Controls Ulcer Recurrence in Patients on Low-dose Aspirin Therapy: A Multicenter Prospective Study.
Topics: Anti-Ulcer Agents; Aspirin; Humans; Peptic Ulcer; Prospective Studies; Rabeprazole; Ulcer | 2023 |